Skip to content

The clinical application of intradermal acupuncture in treating rheumatoid arthritis

The clinical application of intradermal acupuncture in treating rheumatoid arthritis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038028
Enrollment
Unknown
Registered
2020-09-08
Start date
2020-09-25
Completion date
Unknown
Last updated
2020-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

Sponsors

Department of Rheumatology, the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: ? The first diagnosis of Western medicine was rheumatoid arthritis, and the first diagnosis of TCM was Wangbi. ? The diagnostic criteria of western medicine refer to the classification standard of rheumatoid arthritis revised by the American Academy of Rheumatology (ARA) in 1987 and the classification standard of ACR/EULAR rheumatoid arthritis in 2009. The diagnostic criteria of traditional Chinese medicine refer to the standard of the Chinese medicine industry of the Peoples Republic of China, "Standards for Diagnosis and Efficacy of TCM Diseases and Syndromes" (ZY/T001.1-94). ? Syndrome diagnosis refers to the "Eleventh Five-Year" Key Specialty Collaborative Group of the State Administration of Traditional Chinese Medicine, and selects patients with liver and kidney deficiency syndromes. ? DAS28 score belongs to patients with mild activity or inactivity, and still have limb joint pain. ? Aged over 18 years and volunteer to participate in this research.

Exclusion criteria

Exclusion criteria: ? Combined with serious cardiopulmonary disease, liver and kidney disease, diabetes, coronary heart disease, etc. ? Combined with hematological diseases and malignant tumors. ? Pregnant or lactating women. ? Fever or coagulopathy. ? Treatment of local skin ulcers or skin diseases.

Design outcomes

Primary

MeasureTime frame
Evaluation of TCM Syndrome of Patients;DAS28 score;Rheumatoid Arthritis Patient Health Assessment Questionnaire (HAQ) score;

Secondary

MeasureTime frame
Serum CRP;Adverse reactions;

Countries

China

Contacts

Public ContactYang Xiangwei
1327758056@qq.com13570919326

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 22, 2026